HALE DAVID F - Director at Dermata Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
DRMA, DRMAW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by HALE DAVID F since 22 Jul 2025

Reported holdings for HALE DAVID F in Dermata Therapeutics, Inc.

Form 4 holding Director

Dermata Therapeutics, Inc.

Security class
Common Stock
Shares / value
80,957
Estimated value
Report date
23 Jan 2025
Price
Ownership
By Hale BioPharma Ventures LLC
Form 4 holding Director

Dermata Therapeutics, Inc.

Security class
Warrant (Right to Buy)
Shares / value
78,741
Estimated value
Report date
21 Jan 2025
Price
Ownership
By Hale BioPharma Ventures LLC
Underlying class
Common Stock
Underlying amount

Transaction history for HALE DAVID F in Dermata Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .